S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
Critical asset just had biggest fall on record (Ad)
This healthcare stock making a buzz with 160% growth
This infrastructure construction stock: Is it ready to pop?
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Monday, 2/26/2024
Is Roku worth a second look after the earnings panic selloff?
Critical asset just had biggest fall on record (Ad)
Is The Trade Desk signaling the rebound of digital advertising?
bluebird bio stock is ripe for a 400% institutional short squeeze
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
Critical asset just had biggest fall on record (Ad)
This healthcare stock making a buzz with 160% growth
This infrastructure construction stock: Is it ready to pop?
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Monday, 2/26/2024
Is Roku worth a second look after the earnings panic selloff?
Critical asset just had biggest fall on record (Ad)
Is The Trade Desk signaling the rebound of digital advertising?
bluebird bio stock is ripe for a 400% institutional short squeeze
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
Critical asset just had biggest fall on record (Ad)
This healthcare stock making a buzz with 160% growth
This infrastructure construction stock: Is it ready to pop?
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Monday, 2/26/2024
Is Roku worth a second look after the earnings panic selloff?
Critical asset just had biggest fall on record (Ad)
Is The Trade Desk signaling the rebound of digital advertising?
bluebird bio stock is ripe for a 400% institutional short squeeze
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
Critical asset just had biggest fall on record (Ad)
This healthcare stock making a buzz with 160% growth
This infrastructure construction stock: Is it ready to pop?
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Monday, 2/26/2024
Is Roku worth a second look after the earnings panic selloff?
Critical asset just had biggest fall on record (Ad)
Is The Trade Desk signaling the rebound of digital advertising?
bluebird bio stock is ripe for a 400% institutional short squeeze

Aptevo Therapeutics (APVO) Short Interest Ratio & Short Volume

$0.14
+0.01 (+7.46%)
(As of 02/26/2024 ET)

Aptevo Therapeutics Short Interest Data

Current Short Volume
16,700 shares
Previous Short Volume
78,900 shares
Change Vs. Previous Month
-78.83%
Dollar Volume Sold Short
$2,715.42
Short Interest Ratio / Days to Cover
0.0
Last Record Date
January 31, 2024
Outstanding Shares
18,840,000 shares
Percentage of Shares Shorted
0.09%
Today's Trading Volume
168,535 shares
Average Trading Volume
302,197 shares
Today's Volume Vs. Average
56%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Aptevo Therapeutics ?

Sign up to receive the latest short interest report for Aptevo Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

APVO Short Interest Over Time

APVO Days to Cover Over Time

APVO Percentage of Float Shorted Over Time


Aptevo Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/202416,700 shares $2,715.42 -78.8%N/A0 $0.16
1/15/202478,900 shares $12,545.10 -61.3%N/A0.2 $0.16
12/31/2023203,900 shares $36,905.90 +253.4%N/A0.3 $0.18
12/15/202357,700 shares $9,924.40 -46.0%N/A0.1 $0.17
11/30/2023106,800 shares $19,971.60 +297.0%N/A0.2 $0.19
11/15/202326,900 shares $4,976.50 -74.2%N/A0.1 $0.19
10/31/2023104,300 shares $29,485.61 -19.3%N/A0.2 $0.28
10/15/2023129,200 shares $41,344.00 +7.4%N/A0.3 $0.32
9/30/2023120,300 shares $39,699.00 +161.5%N/A0.4 $0.33
9/15/202346,000 shares $18,446.00 -46.6%N/A0.1 $0.40
8/31/202386,200 shares $37,928.00 +176.3%N/A0.3 $0.44
8/15/202331,200 shares $11,544.00 -97.8%N/A0.1 $0.37
7/31/20231,390,000 shares $1.45 million +3,837.7%N/A5.6 $1.04
7/15/202335,300 shares $52,950.00 +13.1%N/A0.2 $1.50
6/30/202331,200 shares $45,552.00 +51.5%N/A0.6 $1.46
6/15/202320,600 shares $32,960.00 -59.7%N/A0.4 $1.60
5/31/202351,100 shares $79,716.00 -28.0%N/A1 $1.56
5/15/202371,000 shares $117,150.00 -47.6%N/A1.3 $1.65
4/30/2023135,500 shares $260,160.00 +47.8%N/A2.4 $1.92
4/15/202391,700 shares $174,230.00 -35.1%N/A1.6 $1.90
3/31/2023141,200 shares $287,342.00 +34.2%N/A2 $2.04
3/15/2023105,200 shares $190,412.00 -30.1%N/A1.2 $1.81
2/28/2023150,400 shares $318,848.00 +118.6%N/A0.2 $2.12
2/15/202368,800 shares $141,040.00 -49.1%N/A0.1 $2.05
1/31/2023135,100 shares $310,730.00 -27.3%N/A0.2 $2.30
1/15/2023185,800 shares $418,050.00 -32.3%N/A0.2 $2.25
12/30/2022274,500 shares $636,840.00 -38.8%N/A0.4 $2.32
12/15/2022448,700 shares $1.01 million +764.6%N/A0.6 $2.25
11/30/202251,900 shares $161,928.00 -2.8%N/A1.5 $3.12
11/15/202253,400 shares $178,890.00 -12.3%N/A1.5 $3.35
10/31/202260,900 shares $183,918.00 +6.8%N/A1.3 $3.02
10/15/202257,000 shares $161,310.00 +8.6%N/A0.9 $2.83
9/30/202252,500 shares $159,600.00 +23.8%N/A0.9 $3.04
9/15/202242,400 shares $158,576.00 +3.9%N/A0.7 $3.74
8/31/202240,800 shares $144,432.00 -4.5%N/A0.4 $3.54
8/15/202242,700 shares $195,993.00 -48.9%N/A0.5 $4.59
7/31/202283,500 shares $328,990.00 -9.3%N/A1 $3.94
7/15/202292,100 shares $361,032.00 -30.2%N/A1.3 $3.92
6/30/2022132,000 shares $472,560.00 -24.8%N/A1.4 $3.58
6/15/2022175,600 shares $579,480.00 +20.9%N/A0.8 $3.30













APVO Short Interest - Frequently Asked Questions

What is Aptevo Therapeutics' current short interest?

Short interest is the volume of Aptevo Therapeutics shares that have been sold short but have not yet been covered or closed out. As of January 31st, investors have sold 16,700 shares of APVO short. Learn More on Aptevo Therapeutics' current short interest.

Which institutional investors are shorting Aptevo Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aptevo Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Aptevo Therapeutics' short interest increasing or decreasing?

Aptevo Therapeutics saw a decrease in short interest in the month of January. As of January 31st, there was short interest totaling 16,700 shares, a decrease of 78.8% from the previous total of 78,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Aptevo Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Aptevo Therapeutics: NeuBase Therapeutics, Inc. (0.42%), Notable Labs, Ltd. (0.23%), Clearmind Medicine Inc. (5.40%), Qualigen Therapeutics, Inc. (0.64%), Aravive, Inc. (1.81%), Sonoma Pharmaceuticals, Inc. (0.81%), Cyclacel Pharmaceuticals, Inc. (9.29%), Altamira Therapeutics Ltd. (4.43%), Ensysce Biosciences, Inc. (23.32%), Processa Pharmaceuticals, Inc. (12.47%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Aptevo Therapeutics stock?

Short selling APVO is an investing strategy that aims to generate trading profit from Aptevo Therapeutics as its price is falling. APVO shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Aptevo Therapeutics?

A short squeeze for Aptevo Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of APVO, which in turn drives the price of the stock up even further.

How often is Aptevo Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APVO, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:APVO) was last updated on 2/27/2024 by MarketBeat.com Staff